
Allison M. Fox
Examiner (ID: 18753, Phone: (571)272-2936 , Office: P/1653 )
| Most Active Art Unit | 1653 |
| Art Unit(s) | 1653, 1651, 1633 |
| Total Applications | 1176 |
| Issued Applications | 669 |
| Pending Applications | 124 |
| Abandoned Applications | 396 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20213760
[patent_doc_number] => 12410404
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-09
[patent_title] => Human pluripotent stem cell-based screening for smooth muscle cell differentiation and disease
[patent_app_type] => utility
[patent_app_number] => 16/940090
[patent_app_country] => US
[patent_app_date] => 2020-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 11
[patent_no_of_words] => 10551
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 243
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16940090
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/940090 | Human pluripotent stem cell-based screening for smooth muscle cell differentiation and disease | Jul 26, 2020 | Issued |
Array
(
[id] => 19854555
[patent_doc_number] => 12257367
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-25
[patent_title] => Biomaterials for biological tissue repair
[patent_app_type] => utility
[patent_app_number] => 16/939204
[patent_app_country] => US
[patent_app_date] => 2020-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 32
[patent_no_of_words] => 12958
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16939204
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/939204 | Biomaterials for biological tissue repair | Jul 26, 2020 | Issued |
Array
(
[id] => 16420590
[patent_doc_number] => 20200345788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => HUMAN HEPATOCYTES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/937777
[patent_app_country] => US
[patent_app_date] => 2020-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37649
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16937777
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/937777 | Human hepatocytes and uses thereof | Jul 23, 2020 | Issued |
Array
(
[id] => 16422160
[patent_doc_number] => 20200347358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => SC-BETA CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/934333
[patent_app_country] => US
[patent_app_date] => 2020-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76337
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16934333
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/934333 | SC-beta cells and compositions and methods for generating the same | Jul 20, 2020 | Issued |
Array
(
[id] => 16525539
[patent_doc_number] => 20200399619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => EDITING OF CCR5 RECEPTOR GENE TO PROTECT AGAINST HIV INFECTION
[patent_app_type] => utility
[patent_app_number] => 16/926436
[patent_app_country] => US
[patent_app_date] => 2020-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44565
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16926436
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/926436 | Editing of CCR2 receptor gene to protect against HIV infection | Jul 9, 2020 | Issued |
Array
(
[id] => 16511678
[patent_doc_number] => 20200390935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => SOLUBILIZATION OF ANTIGEN COMPONENTS FOR REMOVAL FROM TISSUES
[patent_app_type] => utility
[patent_app_number] => 16/912586
[patent_app_country] => US
[patent_app_date] => 2020-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23987
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16912586
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/912586 | Solubilization of antigen components for removal from tissues | Jun 24, 2020 | Issued |
Array
(
[id] => 18915771
[patent_doc_number] => 11878037
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-23
[patent_title] => Concurrent activation of regenerative and tolerogenic processes by fibroblast-based compositions for the treatment of multiple sclerosis
[patent_app_type] => utility
[patent_app_number] => 16/887720
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18426
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16887720
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/887720 | Concurrent activation of regenerative and tolerogenic processes by fibroblast-based compositions for the treatment of multiple sclerosis | May 28, 2020 | Issued |
Array
(
[id] => 16252136
[patent_doc_number] => 20200261510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => Therapeutics Using Adipose Cells and Cell Secretions
[patent_app_type] => utility
[patent_app_number] => 16/853569
[patent_app_country] => US
[patent_app_date] => 2020-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25532
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16853569
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/853569 | Therapeutics Using Adipose Cells and Cell Secretions | Apr 19, 2020 | Abandoned |
Array
(
[id] => 16555730
[patent_doc_number] => 20210000878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => Muscle Derived Cells for the Treatment of Gastro-Esophageal Pathologies and Methods of Making and Using the Same
[patent_app_type] => utility
[patent_app_number] => 16/785756
[patent_app_country] => US
[patent_app_date] => 2020-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8966
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16785756
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/785756 | Muscle derived cells for the treatment of gastro-esophageal pathologies and methods of making and using the same | Feb 9, 2020 | Issued |
Array
(
[id] => 16598361
[patent_doc_number] => 20210024892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => Precursor Cells Of Induced Pluripotent Stem Cell (IPSC)-Derived Mesenchymal Stem Cells And Method For Preparing The Same
[patent_app_type] => utility
[patent_app_number] => 16/780050
[patent_app_country] => US
[patent_app_date] => 2020-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6431
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16780050
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/780050 | Precursor Cells Of Induced Pluripotent Stem Cell (IPSC)-Derived Mesenchymal Stem Cells And Method For Preparing The Same | Feb 2, 2020 | Abandoned |
Array
(
[id] => 16557518
[patent_doc_number] => 20210002666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => METHODS OF GENETICALLY MODIFYING ANIMAL CELLS
[patent_app_type] => utility
[patent_app_number] => 16/780522
[patent_app_country] => US
[patent_app_date] => 2020-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6957
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16780522
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/780522 | METHODS OF GENETICALLY MODIFYING ANIMAL CELLS | Feb 2, 2020 | Pending |
Array
(
[id] => 15895253
[patent_doc_number] => 20200147145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => Methods for Reducing the Extent of Light-induced Tissue Inflammation and Injury
[patent_app_type] => utility
[patent_app_number] => 16/747736
[patent_app_country] => US
[patent_app_date] => 2020-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6609
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16747736
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/747736 | Methods for Reducing the Extent of Light-induced Tissue Inflammation and Injury | Jan 20, 2020 | Abandoned |
Array
(
[id] => 17407328
[patent_doc_number] => 11248199
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-15
[patent_title] => Artificial placenta and methods of preparation
[patent_app_type] => utility
[patent_app_number] => 16/746141
[patent_app_country] => US
[patent_app_date] => 2020-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 24
[patent_no_of_words] => 7430
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16746141
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/746141 | Artificial placenta and methods of preparation | Jan 16, 2020 | Issued |
Array
(
[id] => 15828769
[patent_doc_number] => 20200129666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => Variable Density Tissue Graft Composition and Methods of Making and Using the Same
[patent_app_type] => utility
[patent_app_number] => 16/729746
[patent_app_country] => US
[patent_app_date] => 2019-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6752
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16729746
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/729746 | Variable Density Tissue Graft Composition and Methods of Making and Using the Same | Dec 29, 2019 | Abandoned |
Array
(
[id] => 17695941
[patent_doc_number] => 11369643
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-28
[patent_title] => Process of making an amnion derived therapeutic composition
[patent_app_type] => utility
[patent_app_number] => 16/730877
[patent_app_country] => US
[patent_app_date] => 2019-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 28
[patent_no_of_words] => 11680
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16730877
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/730877 | Process of making an amnion derived therapeutic composition | Dec 29, 2019 | Issued |
Array
(
[id] => 16570951
[patent_doc_number] => 20210009957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => CARDIOMYOCYTE PREPARATION AND PREPARATION METHOD THEREFOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/043270
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6704
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17043270
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/043270 | Cardiomyocyte preparation and preparation method therefor and use thereof | Dec 18, 2019 | Issued |
Array
(
[id] => 15994011
[patent_doc_number] => 20200172876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => METHODS FOR SCREENING PERSONAL CARE PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 16/697946
[patent_app_country] => US
[patent_app_date] => 2019-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4331
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16697946
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/697946 | Methods for screening personal care products | Nov 26, 2019 | Issued |
Array
(
[id] => 15960707
[patent_doc_number] => 20200164105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => COMPOSITIONS AND METHODS FOR IMMUNE TOLERANCE
[patent_app_type] => utility
[patent_app_number] => 16/696947
[patent_app_country] => US
[patent_app_date] => 2019-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25846
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16696947
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/696947 | Compositions and methods for immune tolerance | Nov 25, 2019 | Issued |
Array
(
[id] => 15616179
[patent_doc_number] => 20200078494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => Biodegradable Polymer Compositions
[patent_app_type] => utility
[patent_app_number] => 16/686545
[patent_app_country] => US
[patent_app_date] => 2019-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4757
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16686545
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/686545 | Biodegradable Polymer Compositions | Nov 17, 2019 | Abandoned |
Array
(
[id] => 15708861
[patent_doc_number] => 20200101196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => Cancellous Bone Product Including Viable Osteogenic Cells
[patent_app_type] => utility
[patent_app_number] => 16/685942
[patent_app_country] => US
[patent_app_date] => 2019-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5348
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16685942
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/685942 | Cancellous bone product including viable osteogenic cells | Nov 14, 2019 | Issued |